BDBM50120091 CHEMBL110394::N*4*-(2-Chloro-6-methyl-phenyl)-N*7*-(3-dimethylamino-propyl)-imidazo[1,5-a]quinoxaline-4,7-diamine::N4-(2-chloro-6-methylphenyl)-N7-(3-(dimethylamino)propyl)imidazo[1,5-a]quinoxaline-4,7-diamine

SMILES CN(C)CCCNc1ccc2c(c1)nc(Nc1c(C)cccc1Cl)c1cncn21

InChI Key InChIKey=UEPVNPWNWIQJIK-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50120091   

TargetTyrosine-protein kinase Lck(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50120091(N*4*-(2-Chloro-6-methyl-phenyl)-N*7*-(3-dimethylam...)
Affinity DataIC50: 9nMAssay Description:50% inhibition of the phosphorylation of an exogenous substrate by human Lck enzyme.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetTyrosine-protein kinase Lck(Human)
Bristol-Myers Squibb Pharmaceutical Research Institute

Curated by ChEMBL
LigandPNGBDBM50120091(N*4*-(2-Chloro-6-methyl-phenyl)-N*7*-(3-dimethylam...)
Affinity DataIC50: 9nMAssay Description:Inhibition of LckMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed